Proton pump inhibitors and gastric neoplasia

E. J. Kuipers

doi:10.1136/gut.2005.090514

Proton pump inhibitors and gastric neoplasia

E. J. Kuipers^*

^*Corresponding author for this work

Erasmus University Rotterdam

Research output: Contribution to journal › Review article › peer-review

103 Citations (Scopus)

Abstract

Proton pump inhibitors (PPIs) are very effective in maintaining symptomatic and endoscopic remission of acid peptic disorders, such as gastro-oesophageal reflux disease. Side effects with respect to function and morphology of the gastric mucosa are common. Helicobacter pylori eradication can partially prevent and reverse these effects without impairing PPI therapy for gastro-oesophageal reflux disease. This makes long term PPI treatment a safe therapy for patients with acid peptic disorders. The potential side effects of such therapy are discussed here.

Original language	English
Pages (from-to)	1217-1221
Number of pages	5
Journal	Gut
Volume	55
Issue number	9
DOIs	https://doi.org/10.1136/gut.2005.090514
Publication status	Published - Sept 2006
Externally published	Yes

ASJC Scopus Subject Areas

Gastroenterology

Access to Document

10.1136/gut.2005.090514

Cite this

@article{e5153bc595504d61b3f57cc60fcad227,

title = "Proton pump inhibitors and gastric neoplasia",

abstract = "Proton pump inhibitors (PPIs) are very effective in maintaining symptomatic and endoscopic remission of acid peptic disorders, such as gastro-oesophageal reflux disease. Side effects with respect to function and morphology of the gastric mucosa are common. Helicobacter pylori eradication can partially prevent and reverse these effects without impairing PPI therapy for gastro-oesophageal reflux disease. This makes long term PPI treatment a safe therapy for patients with acid peptic disorders. The potential side effects of such therapy are discussed here.",

author = "Kuipers, {E. J.}",

year = "2006",

month = sep,

doi = "10.1136/gut.2005.090514",

language = "English",

volume = "55",

pages = "1217--1221",

journal = "Gut",

issn = "0017-5749",

publisher = "BMJ Publishing Group",

number = "9",

}

TY - JOUR

T1 - Proton pump inhibitors and gastric neoplasia

AU - Kuipers, E. J.

PY - 2006/9

Y1 - 2006/9

N2 - Proton pump inhibitors (PPIs) are very effective in maintaining symptomatic and endoscopic remission of acid peptic disorders, such as gastro-oesophageal reflux disease. Side effects with respect to function and morphology of the gastric mucosa are common. Helicobacter pylori eradication can partially prevent and reverse these effects without impairing PPI therapy for gastro-oesophageal reflux disease. This makes long term PPI treatment a safe therapy for patients with acid peptic disorders. The potential side effects of such therapy are discussed here.

AB - Proton pump inhibitors (PPIs) are very effective in maintaining symptomatic and endoscopic remission of acid peptic disorders, such as gastro-oesophageal reflux disease. Side effects with respect to function and morphology of the gastric mucosa are common. Helicobacter pylori eradication can partially prevent and reverse these effects without impairing PPI therapy for gastro-oesophageal reflux disease. This makes long term PPI treatment a safe therapy for patients with acid peptic disorders. The potential side effects of such therapy are discussed here.

UR - http://www.scopus.com/inward/record.url?scp=33747770334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747770334&partnerID=8YFLogxK

U2 - 10.1136/gut.2005.090514

DO - 10.1136/gut.2005.090514

M3 - Review article

C2 - 16905689

AN - SCOPUS:33747770334

SN - 0017-5749

VL - 55

SP - 1217

EP - 1221

JO - Gut

JF - Gut

IS - 9

ER -

Proton pump inhibitors and gastric neoplasia

Abstract

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this